Global AI-based Clinical Trials Solution Provider Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends
Publisher : MRA | Format : PDF
Global AI-based Clinical Trials Solution Provider Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Supportive initiatives by the public and private sector for R&D with respect to various therapeutic areas, rising adoption of AI-based technologies among pharmaceutical companies and academia, and growing penetration of artificial intelligence (AI), are among the factors driving the market.
AI-based Clinical Trials Solution Provider report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global AI-based Clinical Trials Solution Provider market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Demand from Pharmaceutical Companies and Academia are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for AI-based Clinical Trials Solution Provider industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, AI-based Clinical Trials Solution Provider key companies include Unlearn.AI, Inc., Saama Technologies, Antidote Technologies, Inc., Phesi, Deep 6 AI, Innoplexus, Mendel.ai, Intelligencia and Median Technologies, etc. Unlearn.AI, Inc., Saama Technologies, Antidote Technologies, Inc. are top 3 players and held % share in total in 2023.
AI-based Clinical Trials Solution Provider can be divided into Phase-I, Phase-II and Phase-III,, etc. Phase-I is the mainstream product in the market, accounting for % share globally in 2023.
AI-based Clinical Trials Solution Provider is widely used in various fields, such as Pharmaceutical Companies, Academia and Others,, etc. Pharmaceutical Companies provides greatest supports to the AI-based Clinical Trials Solution Provider industry development. In 2023, global % share of AI-based Clinical Trials Solution Provider went into Pharmaceutical Companies filed.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global AI-based Clinical Trials Solution Provider market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Unlearn.AI, Inc.
Saama Technologies
Antidote Technologies, Inc.
Phesi
Deep 6 AI
Innoplexus
Mendel.ai
Intelligencia
Median Technologies
Symphony AI
BioAge Labs, Inc.
AiCure, LLC
CONSILX
DEEP LENS AI
Halo Health Systems
Pharmaseal
Ardigen
Trials.Ai
Koneksa Health
Euretos
BioSymetrics
Google- Verily
GNS Healthcare
IBM Watson
Exscientia
Segment by Type
Phase-I
Phase-II
Phase-III
Pharmaceutical Companies
Academia
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the AI-based Clinical Trials Solution Provider market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, AI-based Clinical Trials Solution Provider introduction, etc. AI-based Clinical Trials Solution Provider Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRA Research’s Conclusions of AI-based Clinical Trials Solution Provider market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRA Research.
AI-based Clinical Trials Solution Provider report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global AI-based Clinical Trials Solution Provider market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Demand from Pharmaceutical Companies and Academia are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for AI-based Clinical Trials Solution Provider industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, AI-based Clinical Trials Solution Provider key companies include Unlearn.AI, Inc., Saama Technologies, Antidote Technologies, Inc., Phesi, Deep 6 AI, Innoplexus, Mendel.ai, Intelligencia and Median Technologies, etc. Unlearn.AI, Inc., Saama Technologies, Antidote Technologies, Inc. are top 3 players and held % share in total in 2023.
AI-based Clinical Trials Solution Provider can be divided into Phase-I, Phase-II and Phase-III,, etc. Phase-I is the mainstream product in the market, accounting for % share globally in 2023.
AI-based Clinical Trials Solution Provider is widely used in various fields, such as Pharmaceutical Companies, Academia and Others,, etc. Pharmaceutical Companies provides greatest supports to the AI-based Clinical Trials Solution Provider industry development. In 2023, global % share of AI-based Clinical Trials Solution Provider went into Pharmaceutical Companies filed.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global AI-based Clinical Trials Solution Provider market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Unlearn.AI, Inc.
Saama Technologies
Antidote Technologies, Inc.
Phesi
Deep 6 AI
Innoplexus
Mendel.ai
Intelligencia
Median Technologies
Symphony AI
BioAge Labs, Inc.
AiCure, LLC
CONSILX
DEEP LENS AI
Halo Health Systems
Pharmaseal
Ardigen
Trials.Ai
Koneksa Health
Euretos
BioSymetrics
Google- Verily
GNS Healthcare
IBM Watson
Exscientia
Segment by Type
Phase-I
Phase-II
Phase-III
Segment by Application
Pharmaceutical Companies
Academia
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the AI-based Clinical Trials Solution Provider market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, AI-based Clinical Trials Solution Provider introduction, etc. AI-based Clinical Trials Solution Provider Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRA Research’s Conclusions of AI-based Clinical Trials Solution Provider market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRA Research.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices